MMP9 and colorectal carcinoma: Notably, CRC-bearing rats treated with either PGPs or PGPs-NE at a dosage of 200 mg/body weight for 12 consecutive weeks demonstrated a significant decrease (P < 0.05) in MMP-9 expression compared to the untreated CRC-bearing rats.